Net Asset Value(s)

MKTUPDTE
Thu, Oct 17 2024 08:30 am

Templeton Emerging Markets Investment Trust PLC ('TEMIT')

On behalf of TEMIT, Franklin Templeton Investment Trust Management Limited reports the unaudited cum-income net asset value ('NAV') of TEMIT as at
15 October 2024 was £2083.706m, representing a NAV of 195.93 pence per share.
The unaudited ex-income NAV of TEMIT as at 15 October 2024 was £2043.587m, representing a NAV of 192.16 pence per share.

In accordance with the Association of Investment Companies recommendations, the cum-income NAV has been calculated based on the total value of underlying assets,
including accumulated or accrued income, and using bid price information relating to the underlying assets.
The ex-income NAV has been calculated based on the total value of underlying assets, excluding these income elements, and using bid price information relating to the underlying assets.

Portfolio data for TEMIT can be found on the website www.TEMIT.co.uk.

If the long-term debt was valued at cost, the cum-income NAV would decrease by 0.13p

For information please contact Client Dealer Services on freephone 0800 305 306.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.


Announcement PDF


Markets News

Oh boy, Oboz: KMD Brands' limping footwear segment
Retail

Oh boy, Oboz: KMD Brands' limping footwear segment

 ‘It’s got a lot to iron out,’ Forsyth Barr’s Paul Koraua says.

Markets Market close

NZ sharemarket falls 1.2%

The S&P/NZX 50 Index closed at 13,053.56 points, down 159.36 points or 1.21%.

Graham Skellern 28 Nov 2024
NZ sharemarket falls 1.2%
Markets

F&P Healthcare: don’t mention the tariffs!

Mexican and Chinese plants could face tariffs on exports to the US.

Pattrick Smellie 28 Nov 2024
F&P Healthcare: don’t mention the tariffs!